×
About 38,920 results

ALLMedicine™ Antiretroviral Therapy Center

Research & Reviews  13,907 results

Fifteen years of the proficiency testing program for HIV-1 viral load testing laborator...
https://doi.org/10.1016/j.jcv.2021.104911
Journal of Clinical Virology : the Official Publication O... Jin C, Pan P et. al.

Aug 1st, 2021 - HIV-1 viral load (VL) testing is essential for monitoring the effects of antiretroviral therapy in HIV-infected patients. In order to identify factors that impact testing performance of HIV-1 VL testing laboratories, this study performed a retrosp...

Using financial diaries to understand the economic lives of HIV-positive pregnant women...
https://doi.org/10.1371/journal.pone.0252083
PloS One; Lorenzetti L, Swann M et. al.

Jul 31st, 2021 - Economic strengthening (ES) interventions can address economic barriers to retention and adherence (R&A) to antiretroviral therapy in prevention of mother-to-child transmission (PMTCT) services. To inform tailoring of ES activities for PMTCT, we u...

Assessing national cervical cancer screening guidelines: Results from an HIV testing cl...
https://doi.org/10.1371/journal.pone.0255124
PloS One; Hopkins KL, Jaffer M et. al.

Jul 31st, 2021 - A screening centre in Soweto, South Africa (SA), investigated high-risk human papillomavirus (HR-HPV), HIV, cervical cancer risk amongst women. This cross-sectional study (June 2018-March 2019) describes screening results (Roche Linear Array HPV t...

Poorer Muscle Quality and Quantity with ART Initiation is Associated with Greater Infla...
https://doi.org/10.1097/QAI.0000000000002776
Journal of Acquired Immune Deficiency Syndromes (1999); Kousari A, Moser C et. al.

Jul 31st, 2021 - We have previously shown that initiation of antiretroviral therapy (ART) is associated with a decrease in skeletal muscle density (greater fat accumulation), suggesting that gains in lean body mass seen in many ART studies may reflect gains in low...

In vitro assessment of the potential for dolutegravir to affect hepatic clearance of le...
https://doi.org/10.1111/hiv.13136
HIV Medicine; Roberts O, Kinvig H et. al.

Jul 31st, 2021 - The World Health Organization recommends that all countries adopt dolutegravir-based antiretroviral therapy as the preferred regimen for all individuals living with HIV. Levonorgestrel is a commonly used hormonal contraceptive, which undergoes dru...

see more →

Guidelines  23 results

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Reco...
https://doi.org/10.1001/jama.2020.17025
JAMA Saag MS, Gandhi RT et. al.

Oct 15th, 2020 - Data on the use of antiretroviral drugs, including new drugs and formulations, for the treatment and prevention of HIV infection continue to guide optimal practices. To evaluate new data and incorporate them into current recommendations for initia...

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a pos...
https://doi.org/10.1007/s00198-018-4794-0
Osteoporosis International : a Journal Established as Res... Biver E, Calmy A et. al.

Jan 4th, 2019 - Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general population. Accordingly, age-related comorbidities, including osteoporosis, are increasing. Fracture risk is higher and increases approximately 10 years ...

ACOG Committee Opinion No. 751 Summary: Labor and Delivery Management ofWomenWith Human...
https://doi.org/10.1097/AOG.0000000000002821
Obstetrics and Gynecology;

Aug 23rd, 2018 - This Committee Opinion is being revised to provide updated guidance on the management of pregnant women during pregnancy and delivery to prevent mother-to-child transmission of the human immunodeficiency virus (HIV). Prevention of transmission of ...

ACOG Committee Opinion No. 752 Summary: Prenatal and Perinatal Human Immunodeficiency V...
https://doi.org/10.1097/AOG.0000000000002829
Obstetrics and Gynecology;

Aug 23rd, 2018 - Given the enormous advances in the prevention of perinatal transmission of human immunodeficiency virus (HIV), it is clear that early identification and treatment of all pregnant women with HIV is the best way to prevent neonatal infection and als...

ACOG Committee Opinion No. 751: Labor and Delivery Management of Women With Human Immun...
https://doi.org/10.1097/AOG.0000000000002820
Obstetrics and Gynecology;

Aug 23rd, 2018 - This Committee Opinion is being revised to provide updated guidance on the management of pregnant women during pregnancy and delivery to prevent mother-to-child transmission of the human immunodeficiency virus (HIV). Prevention of transmission of ...

see more →

Drugs  32 results see all →

Clinicaltrials.gov  739 results

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
https://clinicaltrials.gov/ct2/show/NCT00029445

May 7th, 2020 - In an attempt to elucidate the mechanism(s) of immune-mediated restriction of HIV viral replication, we aim to study four groups of individuals: 1) HIV-infected long-term nonprogressors (LTNP), who appear to control HIV primarily through virus-spe...

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients
https://clinicaltrials.gov/ct2/show/NCT00039689

May 6th, 2020 - HIV infection is known to cause profound and irreversible dysfunction of both innate and adaptive arms of the immune system. However, there is mounting evidence that early and aggressive treatment with antiretroviral drugs can prevent loss of immu...

Acceptance and Commitment Therapy for Aging People Living With HIV in Chronic Pain
https://clinicaltrials.gov/ct2/show/NCT03699020

May 6th, 2020 - Chronic pain affects a very high proportion of aging people living with HIV (aPLWH) and is thought to be related to both direct toxicity of HIV and antiretroviral therapy (ART) and by psychosocial factors that negatively affect pain (i.e. loneline...

A Single Dose of Pembrolizumab in HIV-Infected People
https://clinicaltrials.gov/ct2/show/NCT03367754

May 5th, 2020 - A subset of HIV-infected patients, those with poor immunologic response to combined antiretroviral therapy (CD4+ T-cell count of less than 300-350 cells/mm^3) despite control of viremia, are at increased risk for both HIV-related and non-HIV-relat...

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
https://clinicaltrials.gov/ct2/show/NCT02408861

May 5th, 2020 - PRIMARY OBJECTIVES: I. To demonstrate safety and feasibility of ipilimumab and nivolumab at the standard doses of drug in solid tumor and relapsed refractory HIV-classical Hodgkin lymphoma (cHL) participants with human immunodeficiency virus (HIV)...

see more →

News  864 results

Twice-A-Year Lenacapavir Shows Viral Suppression in Drug-Resistant HIV at 26 Weeks
https://www.medscape.com/viewarticle/955114

Jul 20th, 2021 - Dr Jean-Michel Molina The long-acting drug lenacapavir, a first-in-class capsid inhibitor, shows sustained viral suppression in a small cohort of heavily treatment-experienced patients with multidrug-resistant HIV at 26 weeks when combined with an...

HIV: NIDA's Avenir Grant Awarded to Hansel Tookes, MD, MPH, for Tele-Harm Reduction Research
https://www.medscape.com/viewarticle/954836

Jul 15th, 2021 - "There are no interventions that have been shown to be effective in attaining viral suppression in people who inject drugs (PWID)," 2021 HIV/AIDS Research Avenir Award winner Hansel Tookes, MD, infectious disease specialist at the University of Mi...

Prime-boost Regimen of AstraZeneca COVID-19 Vaccine Safe and Effective in People with HIV
https://www.medscape.com/viewarticle/953648

Jun 24th, 2021 - Takeaway The ChAdOx1 nCoV-19 (AZD1222) vaccine given as a prime-boost regimen was well tolerated and produced similar immune responses in individuals with human immunodeficiency virus (HIV) well controlled on antiretroviral therapy (ART) vs those ...

Life Expectancy With HIV on the Increase in Latin America and Caribbean
https://www.medscape.com/viewarticle/950176

Apr 30th, 2021 - NEW YORK (Reuters Health) - Growing availability of antiretroviral therapy (ART) has led to a rise in life expectancy among people living with HIV in Latin America and the Caribbean, according to a new study. Dr. Jessica L. Castilho told Reuters H...

Adverse Metabolic Changes May Accompany Switch From TDF- to TAF-containing Antiretroviral Therapy
https://www.medscape.com/viewarticle/947535

Mar 17th, 2021 - NEW YORK (Reuters Health) - Replacing tenofovir disoproxil fumarate (TDF) with tenofovir alafenamide (TAF) in antiretroviral therapy (ART) regimens raises the risk of significant weight gain and worsening blood lipid levels in people living with H...

see more →

Patient Education  3 results see all →